← ANALYSTS · TIPRANKS
Jack Meehan · Nephron
Hits
68%
131 of 194 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+14.4%
Over a year after the rating, TipRanks’ measure
Our companies rated now
4
Buy / hold / sell: 1 / 3 / 0
Upside of the analyst’s targets
−9.8%
Average over 3 current targets, to the last price
The market’s answer to the ratings
+2.4%
Day-0 move against SPY in the rating’s direction, average over 4 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Mar 26on TipRanks 07:20 | ASPYAgilent · $49.5B | Upgrade | Buy | $145 | −16.2% | +2.2%next day −1.1% · 5 days +0.3% | ↗ |
| Mar 26on TipRanks 07:20 | RVTYSPYRevvity · $17.3B | Upgrade | Hold | $90.00 | −41.0% | +1.0%next day −2.0% · 5 days +0.4% | ↗ |
| Jan 21on TipRanks 07:50 | QGENQiagen · $9.3B | Downgrade | Hold | $59.00 | +27.9% | −0.8%next day −3.1% · 5 days −4.5% | ↗ |
| Nov 3on TipRanks 17:25 | BRKRBruker · $8.6B | Upgrade | Hold | — | — | +5.5%next day −0.8% · 5 days +2.2% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗